Status:
UNKNOWN
The Use of Indocyanine Green Angiography to Predict Expanded Flap Viability
Lead Sponsor:
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Conditions:
Necorsis
Eligibility:
All Genders
5-60 years
Brief Summary
It is a prospective and observational trial that designed to evaluate the effect of intraoperative indocyanine green angiography (ICGA) on prediction of postoperative necrosis and other complications ...
Detailed Description
The lack of suitable soft tissues is a common challenge facing the reconstructive surgeon. Tissue expansion, first described in 1957 by Neumann, is an ingenious technique that can cause body to grow a...
Eligibility Criteria
Inclusion
- Age: 6-50 years old;
- Sex: male and female;
- Undergo expanded flap treatment;
- Possible to suffer from flap necrosis;
- Sign the informed consent and are willing to keep following up
Exclusion
- Present or history of significant medical diseases including infectious, renal, cardiovascular, hepatic, hematological and psychiatric diseases;
- Evidence of infection, ischemia, ulcer or other pathological changes within the targeting area which defined as not suitable for expansion; or history of delayed healing, radiational therapy;
- Long history of smoking and/or drinking (\>5 years) without quit.
- Iodine allergy; Indocyanine green allergy;
- Evidence of psychological disorders, no self-awareness and unable to cooperate;
- Evidence of malignant diseases or unwillingness to participate.
Key Trial Info
Start Date :
November 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04097665
Start Date
November 18 2019
End Date
December 31 2020
Last Update
December 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Ninth People's Hospital
Shanghai, Shanghai Municipality, China, 200011